Osteonecrosis or Metastases of the Jaw or Both? Case Report and Review of the Literature

Journal of Oral and Maxillofacial Surgery

Volumn 68, Issue 5, 2010, Pages 1185-1188

  Otto, Sven ^a   Schuler, Kirsten ^a   Ihrler, Stephan ^a   Ehrenfeld, Michael ^a   Mast, Gerson ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID;

ADULT; ARTICLE; BONE BIOPSY; BONE METASTASIS; BREAST CANCER; CANCER PATIENT; CASE REPORT; CHIN; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPESTHESIA; JAW CANCER; JAW OSTEONECROSIS; PANORAMIC RADIOGRAPHY; PARESTHESIA; TREATMENT OUTCOME;

BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DIPHOSPHONATES; FATAL OUTCOME; FEMALE; HUMANS; HYPESTHESIA; LIP DISEASES; MANDIBULAR DISEASES; MANDIBULAR NEOPLASMS; MIDDLE AGED; OSTEONECROSIS; OSTEOSCLEROSIS; PARESTHESIA;

EID: 77950807148     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2009.09.052     Document Type: Article

References (16)

1. Marx R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg 61 (2003) 1115
2. Yarom N., Yahalom R., Shoshani Y., et al. Osteonecrosis of the jaw induced by orally administered bisphosphonates: Incidence, clinical features, predisposing factors and treatment outcome. Osteoporos Int 18 (2007) 1363
3. Wang E.P., Kaban L.B., Strewler G.J., et al. Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. J Oral Maxillofac Surg 65 (2007) 1328
4. Weitzman R., Sauter N., Eriksen E.F., et al. Critical review: Updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients-May 2006. Crit Rev Oncol Hematol 62 (2007) 148
5. Ruggiero S.L., Dodson T.B., Assael L.A., et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw-2009 update 67 (2009) 2
6. Diel I.J., Bergner R., and Grotz K.A. Adverse effects of bisphosphonates: Current issues. J Support Oncol 5 (2007) 475
7. Mehrotra B. Safety profile of intravenous bisphosphonates. Semin Oncol 34 suppl 4 (2007) S24
8. Khosla S., Burr D., Cauley J., et al. Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22 (2007) 1479
9. American Association of Oral and Maxillofacial Surgeons. Position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65 (2007) 369
10. Bamias A., Kastritis E., Bamia C., et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors. J Clin Oncol 23 (2005) 8580
11. Reid I.R., Bolland M.J., and Grey A.B. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?. Bone 41 (2007) 318
12. Diel I.J., Fogelman I., Al Nawas B., et al. Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?. Crit Rev Oncol Hematol 64 (2007) 198
13. Otto S., Hafner S., and Grotz K.A. The role of inferior alveolar nerve involvement in bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg 67 (2009) 589
14. Bedogni A., Saia G., Ragazzo M., et al. Bisphosphonate-associated osteonecrosis can hide jaw metastases. Bone 41 (2007) 942
15. Abu-Id M.H., Warnke P.H., Gottschalk J., et al. "Bis-phossy jaws"-High and low-risk factors for bisphosphonate-induced osteonecrosis of the jaw. J Craniomaxillofac Surg 36 (2008) 95
16. Shenker N.G., and Jawad A.S. Bisphosphonates and osteonecrosis of the jaw. Rheumatology (Oxf) 46 (2007) 1049